Matches in SemOpenAlex for { <https://semopenalex.org/work/W2279875163> ?p ?o ?g. }
- W2279875163 endingPage "624" @default.
- W2279875163 startingPage "610" @default.
- W2279875163 abstract "Purpose The treatment of systemic lupus erythematosus (SLE) is complex, with a wide range of drugs commonly prescribed. The aims of this study were to identify longitudinal treatment patterns in patients with incident SLE and to estimate the associations of treatment patterns with clinical and economic outcomes. Methods This retrospective, observational cohort study used a US managed care claims database to identify patients with newly diagnosed SLE and 4-year treatment follow-up. Patients were aged ≥18 years, with continuous medical and pharmacy benefits for 12 months before and 48 months after the index date (first medical claim with a diagnosis of SLE). Longitudinal treatment patterns were grouped using a k-means cluster analysis. Therapies were included in the cluster analysis if the mean number of prescriptions in each year was ≥0.05. Clinical and economic outcomes were compared across clusters using multivariate regression analyses. Findings Data from 1611 patients with incident SLE were analyzed (91.4% women; mean [SD] age, 44.5 [9.5] years; 56.2% managed primarily by a specialist). Hydroxychloroquine and corticosteroids were the most commonly prescribed therapies; methotrexate, azathioprine, and mycophenolate mofetil also met the criteria for inclusion in the cluster analysis. Ten treatment clusters were identified; the most common was minimally treated patients (42.8%). Hydroxychloroquine monotherapy, corticosteroid monotherapy, and corticosteroid/hydroxychloroquine combination therapy were received by 34.0%, 11.2%, and 7.8% of patients, respectively. Methotrexate or azathioprine with a corticosteroid/hydroxychloroquine were received by 4.2% of patients. Changes in therapy, except discontinuations, were rare. Compared with the minimally treated cluster, those that received corticosteroid monotherapy (mean dose, >12.0 mg/d) had poorer clinical and economic outcomes; the hydroxychloroquine-monotherapy cluster had similar or better outcomes; and patients who received a corticosteroid/hydroxychloroquine with or without methotrexate or azathioprine demonstrated outcomes that were poorer but that appeared better than those with corticosteroid monotherapy. SLE-related visits with a nonspecialist were common (~45%) and remained unchanged over time despite better clinical and economic outcomes associated with specialist visits. Implications This study utilized cluster analysis, an unsupervised machine-learning method, to systematically discern treatment patterns over 4 years and to estimate outcomes associated with the identified treatment patterns. The results suggest that minimal treatment is the most common approach in patients with newly diagnosed SLE. Clinical and economic outcomes are poorest with corticosteroid monotherapy but may improve with the addition of hydroxychloroquine and/or an immunosuppressive agent. A large proportion of SLE care is provided by nonspecialists despite the potential benefits of involving a specialist." @default.
- W2279875163 created "2016-06-24" @default.
- W2279875163 creator A5016771354 @default.
- W2279875163 creator A5029767739 @default.
- W2279875163 creator A5050896734 @default.
- W2279875163 creator A5071090995 @default.
- W2279875163 creator A5071430304 @default.
- W2279875163 creator A5078778411 @default.
- W2279875163 date "2016-03-01" @default.
- W2279875163 modified "2023-09-27" @default.
- W2279875163 title "Longitudinal Treatment Patterns and Associated Outcomes in Patients With Newly Diagnosed Systemic Lupus Erythematosus" @default.
- W2279875163 cites W1498763512 @default.
- W2279875163 cites W1967203954 @default.
- W2279875163 cites W1990460515 @default.
- W2279875163 cites W1992187314 @default.
- W2279875163 cites W1996652136 @default.
- W2279875163 cites W1996722581 @default.
- W2279875163 cites W2000445173 @default.
- W2279875163 cites W2004761057 @default.
- W2279875163 cites W2033609349 @default.
- W2279875163 cites W2040716643 @default.
- W2279875163 cites W2046558944 @default.
- W2279875163 cites W2051655508 @default.
- W2279875163 cites W2052801802 @default.
- W2279875163 cites W2053746535 @default.
- W2279875163 cites W2064628430 @default.
- W2279875163 cites W2075452125 @default.
- W2279875163 cites W2082843424 @default.
- W2279875163 cites W2089448524 @default.
- W2279875163 cites W2096194879 @default.
- W2279875163 cites W2107243338 @default.
- W2279875163 cites W2116749206 @default.
- W2279875163 cites W2121779711 @default.
- W2279875163 cites W2130385572 @default.
- W2279875163 cites W2131457901 @default.
- W2279875163 cites W2136149088 @default.
- W2279875163 cites W2141351444 @default.
- W2279875163 cites W2160388191 @default.
- W2279875163 cites W2169619909 @default.
- W2279875163 cites W2171121999 @default.
- W2279875163 cites W2314925052 @default.
- W2279875163 cites W4235790631 @default.
- W2279875163 cites W4289257252 @default.
- W2279875163 doi "https://doi.org/10.1016/j.clinthera.2016.01.016" @default.
- W2279875163 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26907503" @default.
- W2279875163 hasPublicationYear "2016" @default.
- W2279875163 type Work @default.
- W2279875163 sameAs 2279875163 @default.
- W2279875163 citedByCount "28" @default.
- W2279875163 countsByYear W22798751632016 @default.
- W2279875163 countsByYear W22798751632017 @default.
- W2279875163 countsByYear W22798751632018 @default.
- W2279875163 countsByYear W22798751632019 @default.
- W2279875163 countsByYear W22798751632020 @default.
- W2279875163 countsByYear W22798751632021 @default.
- W2279875163 countsByYear W22798751632022 @default.
- W2279875163 countsByYear W22798751632023 @default.
- W2279875163 crossrefType "journal-article" @default.
- W2279875163 hasAuthorship W2279875163A5016771354 @default.
- W2279875163 hasAuthorship W2279875163A5029767739 @default.
- W2279875163 hasAuthorship W2279875163A5050896734 @default.
- W2279875163 hasAuthorship W2279875163A5071090995 @default.
- W2279875163 hasAuthorship W2279875163A5071430304 @default.
- W2279875163 hasAuthorship W2279875163A5078778411 @default.
- W2279875163 hasConcept C126322002 @default.
- W2279875163 hasConcept C164866538 @default.
- W2279875163 hasConcept C167135981 @default.
- W2279875163 hasConcept C187212893 @default.
- W2279875163 hasConcept C199360897 @default.
- W2279875163 hasConcept C2776760755 @default.
- W2279875163 hasConcept C2776804153 @default.
- W2279875163 hasConcept C2778720950 @default.
- W2279875163 hasConcept C2779123688 @default.
- W2279875163 hasConcept C2779134260 @default.
- W2279875163 hasConcept C3008058167 @default.
- W2279875163 hasConcept C41008148 @default.
- W2279875163 hasConcept C524204448 @default.
- W2279875163 hasConcept C71924100 @default.
- W2279875163 hasConcept C72563966 @default.
- W2279875163 hasConceptScore W2279875163C126322002 @default.
- W2279875163 hasConceptScore W2279875163C164866538 @default.
- W2279875163 hasConceptScore W2279875163C167135981 @default.
- W2279875163 hasConceptScore W2279875163C187212893 @default.
- W2279875163 hasConceptScore W2279875163C199360897 @default.
- W2279875163 hasConceptScore W2279875163C2776760755 @default.
- W2279875163 hasConceptScore W2279875163C2776804153 @default.
- W2279875163 hasConceptScore W2279875163C2778720950 @default.
- W2279875163 hasConceptScore W2279875163C2779123688 @default.
- W2279875163 hasConceptScore W2279875163C2779134260 @default.
- W2279875163 hasConceptScore W2279875163C3008058167 @default.
- W2279875163 hasConceptScore W2279875163C41008148 @default.
- W2279875163 hasConceptScore W2279875163C524204448 @default.
- W2279875163 hasConceptScore W2279875163C71924100 @default.
- W2279875163 hasConceptScore W2279875163C72563966 @default.
- W2279875163 hasIssue "3" @default.
- W2279875163 hasLocation W22798751631 @default.
- W2279875163 hasLocation W22798751632 @default.
- W2279875163 hasOpenAccess W2279875163 @default.